166 related articles for article (PubMed ID: 16261362)
1. Changes to methadone clearance during pregnancy.
Wolff K; Boys A; Rostami-Hodjegan A; Hay A; Raistrick D
Eur J Clin Pharmacol; 2005 Nov; 61(10):763-8. PubMed ID: 16261362
[TBL] [Abstract][Full Text] [Related]
2. Methadone trough levels in pregnancy.
Drozdick J; Berghella V; Hill M; Kaltenbach K
Am J Obstet Gynecol; 2002 Nov; 187(5):1184-8. PubMed ID: 12439500
[TBL] [Abstract][Full Text] [Related]
3. Population-based pharmacokinetic approach for methadone monitoring of opiate addicts: potential clinical utility.
Wolff K; Rostami-Hodjegan A; Hay AW; Raistrick D; Tucker G
Addiction; 2000 Dec; 95(12):1771-83. PubMed ID: 11177493
[TBL] [Abstract][Full Text] [Related]
4. Perinatal effects of combined use of heroin, methadone, and amphetamine during pregnancy and quantitative measurement of metabolites in hair.
Su PH; Chang YZ; Yang C; Ng YY; Chen JY; Chen SC
Pediatr Neonatol; 2012 Apr; 53(2):112-7. PubMed ID: 22503258
[TBL] [Abstract][Full Text] [Related]
5. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
Kakko J; Heilig M; Sarman I
Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
[TBL] [Abstract][Full Text] [Related]
6. Observations on methadone withdrawal in 16 neonates.
Rahbar F
Clin Pediatr (Phila); 1975 Apr; 14(4):369-71. PubMed ID: 1120379
[TBL] [Abstract][Full Text] [Related]
7. Alterations in methadone metabolism during late pregnancy.
Jarvis MA; Wu-Pong S; Kniseley JS; Schnoll SH
J Addict Dis; 1999; 18(4):51-61. PubMed ID: 10631963
[TBL] [Abstract][Full Text] [Related]
8. Altered methadone pharmacokinetics in pregnancy: implications for dosing.
Swift RM; Dudley M; DePetrillo P; Camara P; Griffiths W
J Subst Abuse; 1989; 1(4):453-60. PubMed ID: 2485290
[TBL] [Abstract][Full Text] [Related]
9. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
Binder T; Vavrinková B
Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
[TBL] [Abstract][Full Text] [Related]
10. Altered methadone pharmacokinetics in methadone-maintained pregnant women.
Pond SM; Kreek MJ; Tong TG; Raghunath J; Benowitz NL
J Pharmacol Exp Ther; 1985 Apr; 233(1):1-6. PubMed ID: 3981450
[TBL] [Abstract][Full Text] [Related]
11. The Use of Serum Methadone/Metabolite Ratios to Monitor Changing Perinatal Pharmacokinetics.
McCarthy JJ; Vasti EJ; Leamon MH; Graas J; Ward C; Fassbender C
J Addict Med; 2018; 12(3):241-246. PubMed ID: 29521669
[TBL] [Abstract][Full Text] [Related]
12. Predictors of neonatal outcomes amongst a methadone- and/or heroin-dependent population referred to a multidisciplinary Perinatal and Family Drug Health Service.
Buckley V; Razaghi A; Haber P
Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):464-70. PubMed ID: 23550533
[TBL] [Abstract][Full Text] [Related]
13. [Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature].
Laqueille X; Launay C; Dervaux A; Kanit M
Encephale; 2009 Jun; 35(3):220-5. PubMed ID: 19540407
[TBL] [Abstract][Full Text] [Related]
14. The use of levo-alpha-acetylmethadol (LAAM) in methadone patients who have not achieved heroin abstinence.
Borg L; Ho A; Wells A; Joseph H; Appel P; Moody D; Kreek MJ
J Addict Dis; 2002; 21(3):13-22. PubMed ID: 12094997
[TBL] [Abstract][Full Text] [Related]
15. Maternal and neonatal outcomes following methadone substitution during pregnancy.
Greig E; Ash A; Douiri A
Arch Gynecol Obstet; 2012 Oct; 286(4):843-51. PubMed ID: 22584603
[TBL] [Abstract][Full Text] [Related]
16. Methadone assays in pregnant women and progeny.
Blinick G; Inturrisi CE; Jerez E; Wallach RC
Am J Obstet Gynecol; 1975 Mar; 121(5):617-21. PubMed ID: 1115163
[TBL] [Abstract][Full Text] [Related]
17. Methadone maintenance program in a Swiss perinatal center: (I): Management and outcome of 89 pregnancies.
Kashiwagi M; Arlettaz R; Lauper U; Zimmermann R; Hebisch G
Acta Obstet Gynecol Scand; 2005 Feb; 84(2):140-4. PubMed ID: 15683373
[TBL] [Abstract][Full Text] [Related]
18. Maternal methadone dose and neonatal withdrawal.
Berghella V; Lim PJ; Hill MK; Cherpes J; Chennat J; Kaltenbach K
Am J Obstet Gynecol; 2003 Aug; 189(2):312-7. PubMed ID: 14520184
[TBL] [Abstract][Full Text] [Related]
19. Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships.
Dyer KR; Foster DJ; White JM; Somogyi AA; Menelaou A; Bochner F
Clin Pharmacol Ther; 1999 Jun; 65(6):685-94. PubMed ID: 10391674
[TBL] [Abstract][Full Text] [Related]
20. Obstetric and neonatal outcomes associated with maternal naltrexone exposure.
Hulse GK; O'Neill G; Pereira C; Brewer C
Aust N Z J Obstet Gynaecol; 2001 Nov; 41(4):424-8. PubMed ID: 11787918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
